Who
Simon Dumesnil
Director
Company insider
Files Form 4 as: Director, Pasithea Therapeutics.
In numbers
- Trades disclosed
- 9
- Buys
- 1
- Sells
- 0
- Bought
- $25K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 2 Aug 2021
- Last trade
- 1 May 2026
- Last filed
- 5 May 2026
Companies traded
Activity over time
1 Nov 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 May 2026filed 5 May 2026 | KTTA Pasithea Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —152,783 at $0.00 | filing |
| 1 May 2026filed 5 May 2026 | KTTA Pasithea Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —152,783 at $0.00 | filing |
| 28 Nov 2025filed 1 Dec 2025 | KTTA Pasithea TherapeuticsBiotechnology | SEC FORM 4 Bought | $25K33,333 at $0.75 | filing |
| 24 Oct 2025filed 27 Oct 2025 | KTTA Pasithea Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —42,913 at $0.00 | filing |
| 1 Mar 2024filed 5 Apr 2024 | KTTA Pasithea Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —7,500 at $0.00 | filing |
| 1 Mar 2024filed 1 Mar 2024 | KTTA Pasithea Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —7,500 at $0.00 | filing |
| 17 Nov 2022filed 17 Nov 2022 | KTTA Pasithea TherapeuticsBiotechnology | SEC FORM 4 Code A | $42K40,000 at $1.06 | filing |
| 15 Nov 2022filed 17 Nov 2022 | KTTA Pasithea TherapeuticsBiotechnology | SEC FORM 4 Code A | $11K10,000 at $1.07 | filing |
| 2 Aug 2021filed 17 Nov 2022 | KTTA Pasithea Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.